{"id":"W3185845820","doi":"10.1016/j.jacc.2021.04.102","title":"Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol","year":2021,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta; St. Michael's Hospital","funders":"National Heart, Lung, and Blood Institute; National Institute for Health and Care Research; Sanofi","keywords":"Alirocumab; Medicine; Interquartile range; PCSK9; Hazard ratio; Internal medicine; Statin; Mace; Ezetimibe; Evolocumab; Acute coronary syndrome; Placebo; Atorvastatin; Gastroenterology; Lipoprotein; Confidence interval; Cholesterol; Myocardial infarction; Percutaneous coronary intervention; LDL receptor; Apolipoprotein A1","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001502338,0.0003645968,0.0007689723,0.0002183328,0.0001609818,0.0006411692,0.0001676505,0.0004233136,0.001858267],"category_scores_gemma":[0.002667025,0.0001576512,0.00113756,0.0002480224,0.0003296683,0.0003242849,0.0003310977,0.0008854885,0.0001151489],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004058128,"about_ca_system_score_gemma":0.0004276967,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006616675,"about_ca_topic_score_gemma":0.001111653,"domain_scores_codex":[0.9995347,0.0001947643,0.0000738105,0.00008537283,0.00006500238,0.00004629686],"domain_scores_gemma":[0.9985833,0.0006454267,0.0004053998,0.00007100639,0.00005624025,0.0002386638],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5251836,0.001906245,0.3670382,0.0009405852,0.007114377,0.0002291963,0.0001231677,0.001844323,0.008312729,0.0004987632,0.001793434,0.08501541],"study_design_scores_gemma":[0.08290622,0.04500004,0.8537903,0.0002007288,0.007705411,0.0004312559,0.0001520325,0.003340464,0.002412182,0.001481557,0.002530319,0.00004941349],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939956,0.004248725,0.0001764294,0.0003617499,0.00004821035,0.00005342877,0.0002068344,0.000008612143,0.0009003896],"genre_scores_gemma":[0.9988075,0.0004252887,0.0002214852,0.000194984,0.00006586759,0.0000228477,0.0001514445,0.000001233752,0.0001093093],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001858267,"threshold_uncertainty_score":0.00794518,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005113241267602943,"score_gpt":0.2186444407473924,"score_spread":0.2135311994797895,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}